Description

CLOPIGOLD A 150 Clopidogrel 75 mg + Aspirin 150 mg TABS CLOPIGOLD A 150 is a common and effective treatment strategy used in the prevention of blood clots that can lead to events such as heart attacks and strokes, especially in patients with a high risk of these events. This combination therapy capitalizes on the synergistic effects of two antiplatelet agents, each working through a different mechanism, to provide a more comprehensive approach to reducing the risk of clot formation. Below is an overview of the use, mechanism of action, dosing, side effects, and precautions for CLOPIGOLD A 150 . Uses CLOPIGOLD A 150 is primarily used in: Secondary prevention of cardiovascular events: In patients who have already experienced a heart attack, stroke, or have established peripheral arterial disease. Acute Coronary Syndrome (ACS): For patients presenting with ACS, including those undergoing percutaneous coronary intervention (PCI) with stent placement. Stroke prevention: In certain patients who have had or are at risk of having a stroke, this combination may be recommended. Mechanism of Action Clopidogrel inhibits platelet aggregation by irreversibly inhibiting the binding of adenosine diphosphate (ADP) to platelet receptors, thereby blocking the ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. Aspirin works by irreversibly inhibiting cyclooxygenase-1 (COX-1) enzyme, which reduces the production of thromboxane A2, a molecule that causes platelets to clump together. Together, these drugs provide a dual approach to preventing platelet aggregation, significantly reducing the risk of clot formation.